News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,173 Results
Type
Article (50828)
Company Profile (309)
Press Release (710023)
Multimedia
Podcasts (129)
Webinars (20)
Section
Business (218745)
Career Advice (2571)
Deals (37368)
Drug Delivery (118)
Drug Development (85414)
Employer Resources (179)
FDA (17135)
Job Trends (16011)
News (369194)
Policy (35520)
Tag
Academia (2755)
Academic (1)
Accelerated approval (13)
Adcomms (25)
Allergies (108)
Alliances (54102)
ALS (127)
Alzheimer's disease (1552)
Antibody-drug conjugate (ADC) (176)
Approvals (17156)
Artificial intelligence (392)
Autoimmune disease (34)
Automation (22)
Bankruptcy (375)
Best Places to Work (12090)
BIOSECURE Act (21)
Biosimilars (138)
Biotechnology (197)
Bladder cancer (105)
Brain cancer (42)
Breast cancer (412)
Cancer (3275)
Cardiovascular disease (255)
Career advice (2169)
Career pathing (33)
CAR-T (208)
CDC (37)
Cell therapy (571)
Cervical cancer (26)
Clinical research (70412)
Collaboration (1191)
Company closure (4)
Compensation (794)
Complete response letters (37)
COVID-19 (2820)
CRISPR (71)
C-suite (439)
Cystic fibrosis (125)
Data (3429)
Decentralized trials (2)
Denatured (41)
Depression (75)
Diabetes (377)
Diagnostics (6701)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (174)
Drug pricing (159)
Drug shortages (32)
Duchenne muscular dystrophy (168)
Earnings (93321)
Editorial (52)
Employer branding (22)
Employer resources (156)
Events (122486)
Executive appointments (927)
FDA (19235)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1046)
Gene editing (151)
Generative AI (34)
Gene therapy (458)
GLP-1 (907)
Government (4930)
Grass and pollen (7)
Guidances (327)
Healthcare (19748)
HIV (42)
Huntington's disease (31)
IgA nephropathy (50)
Immunology and inflammation (184)
Immuno-oncology (15)
Indications (44)
Infectious disease (3011)
Inflammatory bowel disease (166)
Inflation Reduction Act (12)
Influenza (76)
Intellectual property (148)
Interviews (441)
IPO (17072)
IRA (58)
Job creations (4321)
Job search strategy (1818)
Kidney cancer (13)
Labor market (60)
Layoffs (556)
Leadership (27)
Legal (8898)
Liver cancer (83)
Longevity (12)
Lung cancer (453)
Lymphoma (241)
Machine learning (16)
Management (61)
Manufacturing (496)
MASH (109)
Medical device (14018)
Medtech (14031)
Mergers & acquisitions (21092)
Metabolic disorders (964)
Multiple sclerosis (107)
NASH (19)
Neurodegenerative disease (154)
Neuropsychiatric disorders (40)
Neuroscience (2359)
NextGen: Class of 2025 (6976)
Non-profit (4797)
Now hiring (53)
Obesity (484)
Opinion (276)
Ovarian cancer (109)
Pain (138)
Pancreatic cancer (137)
Parkinson's disease (204)
Partnered (25)
Patents (360)
Patient recruitment (227)
Peanut (54)
People (61750)
Pharmaceutical (91)
Pharmacy benefit managers (25)
Phase I (21789)
Phase II (30840)
Phase III (23238)
Pipeline (2319)
Policy (254)
Postmarket research (2876)
Preclinical (9463)
Press Release (70)
Prostate cancer (163)
Psychedelics (42)
Radiopharmaceuticals (268)
Rare diseases (548)
Real estate (6540)
Recruiting (69)
Regulatory (24677)
Reports (52)
Research institute (2480)
Resumes & cover letters (415)
Rett syndrome (10)
RNA editing (13)
RSV (56)
Schizophrenia (108)
Series A (172)
Series B (125)
Service/supplier (14)
Sickle cell disease (72)
Special edition (23)
Spinal muscular atrophy (153)
Sponsored (35)
Startups (3865)
State (2)
Stomach cancer (16)
Supply chain (86)
Tariffs (80)
The Weekly (86)
Vaccines (907)
Venture capital (60)
Weight loss (320)
Women's health (51)
Worklife (17)
Date
Last 7 days (569)
Last 30 days (2439)
Last 365 days (32520)
2025 (21280)
2024 (36532)
2023 (41317)
2022 (52580)
2021 (57260)
2020 (56000)
2019 (48988)
2018 (37030)
2017 (34335)
2016 (34341)
2015 (40243)
2014 (34554)
2013 (30052)
2012 (31913)
2011 (32373)
2010 (30740)
Location
Africa (925)
Alabama (69)
Alaska (7)
Arizona (263)
Arkansas (14)
Asia (43653)
Australia (7105)
California (8392)
Canada (2598)
China (782)
Colorado (358)
Connecticut (379)
Delaware (224)
Europe (95821)
Florida (1261)
Georgia (283)
Hawaii (2)
Idaho (61)
Illinois (712)
India (39)
Indiana (408)
Iowa (18)
Japan (255)
Kansas (114)
Kentucky (32)
Louisiana (16)
Maine (67)
Maryland (1150)
Massachusetts (6303)
Michigan (267)
Minnesota (501)
Mississippi (4)
Missouri (103)
Montana (28)
Nebraska (26)
Nevada (94)
New Hampshire (72)
New Jersey (2343)
New Mexico (30)
New York (2305)
North Carolina (1226)
North Dakota (10)
Northern California (3753)
Ohio (262)
Oklahoma (17)
Oregon (40)
Pennsylvania (1796)
Puerto Rico (17)
Rhode Island (40)
South America (1310)
South Carolina (42)
South Dakota (1)
Southern California (3202)
Tennessee (136)
Texas (1297)
United States (31092)
Utah (249)
Virginia (223)
Washington D.C. (76)
Washington State (694)
West Virginia (4)
Wisconsin (83)
761,173 Results for "a and g pharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Protagonist Enters Obesity Fray With Triple-G Pill, Eyeing 2026 Clinical Start
With PN-477, Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II trial.
July 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers
August 29, 2025
·
3 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
April 2, 2025
·
2 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2025 Results and Provides Business Update
August 12, 2025
·
11 min read
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Press Releases
Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase
May 22, 2025
·
8 min read
Press Releases
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
August 28, 2025
·
4 min read
Press Releases
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
August 27, 2025
·
4 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update
August 13, 2025
·
11 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
August 28, 2025
·
5 min read
1 of 76,118
Next
